Winterberg, D.; Lenk, L.; Oßwald, M.; Vogiatzi, F.; Gehlert, C.L.; Frielitz, F.-S.; Klausz, K.; Rösner, T.; Valerius, T.; Trauzold, A.;
et al. Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo. J. Clin. Med. 2021, 10, 2634.
https://doi.org/10.3390/jcm10122634
AMA Style
Winterberg D, Lenk L, Oßwald M, Vogiatzi F, Gehlert CL, Frielitz F-S, Klausz K, Rösner T, Valerius T, Trauzold A,
et al. Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo. Journal of Clinical Medicine. 2021; 10(12):2634.
https://doi.org/10.3390/jcm10122634
Chicago/Turabian Style
Winterberg, Dorothee, Lennart Lenk, Maren Oßwald, Fotini Vogiatzi, Carina Lynn Gehlert, Fabian-Simon Frielitz, Katja Klausz, Thies Rösner, Thomas Valerius, Anna Trauzold,
and et al. 2021. "Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo" Journal of Clinical Medicine 10, no. 12: 2634.
https://doi.org/10.3390/jcm10122634
APA Style
Winterberg, D., Lenk, L., Oßwald, M., Vogiatzi, F., Gehlert, C. L., Frielitz, F. -S., Klausz, K., Rösner, T., Valerius, T., Trauzold, A., Peipp, M., Kellner, C., & Schewe, D. M.
(2021). Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo. Journal of Clinical Medicine, 10(12), 2634.
https://doi.org/10.3390/jcm10122634